微针贴片与无微流体芯片集成,用于异质药物输送
Ji Won Park1, Hye Jin Choi1,2, Min Chul Shin1
1School of Mechanical Engineering, Kyungpook National University, Daegu, 41566, South Korea. gyuman.kim@knu.ac.kr.
Lab on a chip
|October 23, 2025
概括
这项研究引入了一种增强型微针 (MN) 补丁,与无微流体装置集成,以改善通过皮肤递送药物. 与现有的MNs相比,新系统显著提高了药物储存和输送效率.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 药物输送系统 药物输送系统
背景情况:
- 微针 (MN) 设备提供最少的侵入性,无痛的通过皮肤递送药物.
- 现有的MN系统在药物储存能力和药物输送效率方面存在局限性.
研究的目的:
- 通过将MN与无微流体 (MF) 装置集成来开发先进的药物输送系统.
- 提高药物储存和通过皮肤递送的效率.
主要方法:
- 开发了聚烯 (PVP) -M聚合物微针,以提高机械强度.
- 使用多孔涂层方法来增加MN表面积和药物存储.
- 设计了一种以毛细血管力驱动的无微流体装置,用于释放药物.
主要成果:
- 综合系统显示,与传统涂层MNs相比,药物储存和输送显著增强.
- 孔隙涂层和MF设备设计提高了整体传输效率.
- 该系统使MNs和MF设备中的不同药物类型的双重药物输送成为可能.
结论:
- 拟议的综合MN和无MF系统提供了一个强大,简单和灵活的解决方案,用于增强透皮药物输送.
- 预计这项创新将对生物医学领域作出重大贡献.
- 该系统能够促进双重药物输送,这为治疗开辟了新的可能性.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.


